210 related articles for article (PubMed ID: 4999068)
1. The role of RH antibodies in causing haemolytic disease of the newborn and in preventing it.
Mollison PL
J Clin Pathol; 1971 Jul; 24(5):479-80. PubMed ID: 4999068
[No Abstract] [Full Text] [Related]
2. Preventing Rh haemolytic disease.
Scott JS
Br Med J; 1978 Aug; 2(6137):634-5. PubMed ID: 100165
[No Abstract] [Full Text] [Related]
3. [Rhesus immunoprevention by means of immunoglobulin anti-D].
Maas DH; Schneider
Med Monatsschr; 1975 Aug; 29(8):340-7. PubMed ID: 813106
[No Abstract] [Full Text] [Related]
4. Rhesus haemolytic disease.
Whittle MJ
Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
[No Abstract] [Full Text] [Related]
5. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
Dooren MC; Engelfriet CP
Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
[TBL] [Abstract][Full Text] [Related]
6. [Immunization hemolytic disease of the newborn (HDN) Rh with anti-D immunoglobulins].
Moggian G; Tamburini E
Ann Sclavo; 1974; 16(1):91-100. PubMed ID: 4214488
[No Abstract] [Full Text] [Related]
7. [Clinical and laboratory contribution to the prevention of fetal hemoblastosis].
Carbonini M; Follini G
Ann Ostet Ginecol Med Perinat; 1972 Aug; 93(8):579-84. PubMed ID: 4202141
[No Abstract] [Full Text] [Related]
8. Rh hemolytic disease of the newborn--the disease eradicated by immunology.
Zipursky A
Clin Obstet Gynecol; 1977 Sep; 20(3):759-72. PubMed ID: 408069
[No Abstract] [Full Text] [Related]
9. [Relationship between maternal HL-A immunization and familial prognosis of haemolytic disease of the newborn due to Rh incompatibility].
Malinvaud G; Gualde N
Rev Fr Transfus Immunohematol; 1975 Sep; 18(3):269-80. PubMed ID: 821129
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of severe haemolytic disease of the newborn.
Kinnock S; Liley AW
N Z Med J; 1970 Feb; 71(453):76-83. PubMed ID: 4986220
[No Abstract] [Full Text] [Related]
11. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
Bergmann H; Leinzinger E; Pazdernik I; Haider M
Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
[No Abstract] [Full Text] [Related]
12. Intensive plasmapheresis as a therapeutic measure in Rhesus-immunised women.
Clarke CA; Elson CJ; Bradley J; Donohoe WT; Lehane D; Hughes-Jones NC
Lancet; 1970 Apr; 1(7651):793-8. PubMed ID: 4191432
[No Abstract] [Full Text] [Related]
13. [Immune-prevention of fetal erythroblastosis].
Schubert W
Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879
[No Abstract] [Full Text] [Related]
14. [The anti-Rh D immunoglobulin and the use of plasmapheresis as an improvement of its production].
KuĊnierz G; Klenowska Z
Ginekol Pol; 1976 Feb; 47(2):225-32. PubMed ID: 815143
[No Abstract] [Full Text] [Related]
15. The introduction of human monoclonal anti-D for therapeutic use.
Fletcher A; Thomson A
Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
[No Abstract] [Full Text] [Related]
16. The prevention of rhesus-isoimmunization.
Davey M
Clin Obstet Gynaecol; 1979 Dec; 6(3):509-30. PubMed ID: 92385
[No Abstract] [Full Text] [Related]
17. A Canadian Christmas.
Sherrington AM
Can Med Assoc J; 1980 Dec; 123(11):1089. PubMed ID: 6780178
[No Abstract] [Full Text] [Related]
18. Rh(D) haemolytic disease of the newborn: the changing scene.
Urbaniak SJ
Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
[No Abstract] [Full Text] [Related]
19. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D.
Br Med J (Clin Res Ed); 1981 Aug; 283(6290):514-5. PubMed ID: 6790046
[No Abstract] [Full Text] [Related]
20. Prevention of haemolytic disease of the newborn due to anti-D.
Tovey G; Wagstaff W
Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
